Clinical Implications of Thermal Therapy in Lifestyle-Related Diseases

Experimental Biology and Medicine

Volumn 228, Issue 10, 2003, Pages 1245-1249

  Biro, Sadatoshi ^a   Masuda, Akinori ^a   Kihara, Takashi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Endothelial function; Lifestyle related diseases; Sauna; Thermal therapy

Indexed keywords

GHRELIN; MESSENGER RNA;

ADULT; ATHEROSCLEROSIS; BODY FAT; CALORIC INTAKE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; FEEDING BEHAVIOR; FEMALE; HEART FUNCTION; HUMAN; HYDROTHERAPY; HYPERLIPIDEMIA; HYPERTENSION; HYPERTHERMIC THERAPY; LIFESTYLE; MALE; OBESITY; SAUNA; SMOKING HABIT; SPA TREATMENT; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0242525211     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322801023     Document Type: Conference Paper

References (41)

1. Tei C, Horikiri Y, Park JC, Jeong JW, Chang KS, Toyama Y, Tanaka N. Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation 91:2582-2590, 1995.
2. Tei C, Tanaka N. Thermal vasodilation as a treatment of congestive heart failure: A novel approach. J Cardiol 27:29-30, 1996.
3. Tei C. Thermal therapy for congestive heart failure: Estimation by TEI index. J Cardiol 37:155-159, 2001.
4. Kihara T, Biro S, Imamura M, Yoshifuku S, Takasaki K, Ikeda Y, Otuji Y, Minagoe S, Toyama Y, et al. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol 39:754-759, 2002.
5. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84:1589-1596, 1991.
6. Ikeda Y, Biro S, Kamogawa Y, Yoshifuku S, Eto H, Orihara K, Kihara T, Tei C. Repeated thermal therapy upregulates arterial endothelial nitric oxide synthase expression in Syrian golden hamsters. Jpn Circ J 65:434-438, 2001.
7. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: A review. Clin Cardiol 20:426-432, 1997.
8. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23:168-175, 2003.
9. Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit 7:1075-1085, 2001.
10. Behrendt D, Ganz P. Endothelial function: From vascular biology to clinical applications. Am J Cardiol 90(10C):40L-48L, 2002.
11. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046-1051, 1986.
12. Hamasaki S, Higano ST, Suwaidi JA, Nishimura RA, Miyauchi K, Holmes DR Jr, Lerman A. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries. Arterioscler Thromb Vasc Biol 20:737-743, 2000.
13. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265, 2002.
14. Perreault M, Dombrowski L, Marette A. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats. Diabetologia 43:427-437, 2000.
15. Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31:643-648, 1998.
16. Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 19:819-825, 1998.
17. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551, 1993.
18. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors. Circ Res 86:E85-E90, 2000.
19. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 83:652-660, 1991.
20. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897-905, 1999.
21. Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, Otsuji Y, Minagoe S, Toyama Y, Tei C. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 38:1083-1088, 2001.
22. Hooper PL. Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med 341:924-925, 1999.
23. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404:661-671, 2000.
24. Zhang Y, Proenca R, Maffei M, Borone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994.
25. Rohner JF, Cusin I, Sainsbury A, Zakrzewska KE, Jeanrenaud B. The loop system between neuropeptide Y and leptin in normal and obese rodents. Horm Metab Res 28:642-648, 1996.
26. Ahima RS, Prabakaran D, Mantzoros C. Role of leptin in the neuroendocrinology of fasting. Nature 382:250-252, 1996.
27. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999.
28. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141:4255-4261, 2000.
29. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 407:908-913, 2000.
30. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547, 2001.
31. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409:194-198, 2001.
32. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328, 2000.
33. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992-5995, 2001.
34. Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway: A link between adipose tissue mass and central neural networks. Horm Metab Res 28:619-632, 1996.
35. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: The tale of an obesity gene. Diabetes 45:1455-1462, 1996.
36. Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 87:240-244, 2002.
37. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 50:707-709, 2001.
38. Kopelman PG. Obesity as a medical problem. Nature 404:635-643, 2000.
39. Lew EA. Mortality and weight: Insured lives and the American Cancer Society Studies. Ann Intern Med 103:1024-1029, 1985.
40. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R. Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24:RC19-RC21, 2001.
41. English PJ, Ghatei MA, Malik IA, Bloom SR, Wilding JPH. Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab 87:2984-2987, 2002.